User profiles for "author:Rebecca Metcalfe"

Rebecca Metcalfe

University of British Columbia
Verified email at alumni.ubc.ca
Cited by 477

An examination of the relationship between childhood emotional abuse and borderline personality disorder features: The role of difficulties with emotion regulation

JR Kuo, JE Khoury, R Metcalfe, S Fitzpatrick… - Child abuse & …, 2015 - Elsevier
Childhood abuse has been consistently linked with borderline personality disorder (BPD)
and recent studies suggest that some forms of childhood abuse might be uniquely related to …

[HTML][HTML] Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All

R Kean, C Delaney, R Rajendran, L Sherry, R Metcalfe… - Journal of Fungi, 2018 - mdpi.com
Despite their clinical significance and substantial human health burden, fungal infections
remain relatively under-appreciated. The widespread overuse of antibiotics and the …

Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole

L Sherry, R Kean, E McKloud… - Antimicrobial agents …, 2017 - Am Soc Microbiol
Vulvovaginal candidiasis (VVC) is a global health problem affecting∼ 75% of women at
least once in their lifetime. Here we examined the epidemiology of VVC in a patient cohort to …

A multi-method laboratory investigation of emotional reactivity and emotion regulation abilities in borderline personality disorder

JR Kuo, S Fitzpatrick, RK Metcalfe, S McMain - Journal of behavior therapy …, 2016 - Elsevier
Background and objectives Borderline personality disorder (BPD) is conceptualized as a
disorder of heightened emotional reactivity and difficulties with emotion regulation. However …

Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a Person-Centered Scale (Best-Worst Scaling)

S Dobischok, R Metcalfe, E Matzinger, H Palis… - International Journal of …, 2023 - Elsevier
Background Injectable opioid agonist treatment (iOAT) is effective for opioid use disorder
(OUD), yet little is known about client preferences for accessing iOAT (eg, with …

[PDF][PDF] British HIV Association guidelines for the management of HIV in pregnancy and postpartum 2018

Y Gilleece, S Tariq, A Bamford, S Bhagani… - HIV …, 2019 - discovery.ucl.ac.uk
A key goal of managing HIV in pregnancy and postpartum is to optimise a woman's own
health. Furthermore, one of the major successes in the management of individuals living …

Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysis

A McAuley, NE Palmateer, DJ Goldberg… - The lancet HIV, 2019 - thelancet.com
Background In 2015, an outbreak of HIV was identified among people who inject drugs
(PWID) in the Greater Glasgow and Clyde (GGC) area of Scotland, an area which distributes …

Recurrent Vulvovaginal Candidiasis: a Dynamic Interkingdom Biofilm Disease of Candida and Lactobacillus

E McKloud, C Delaney, L Sherry, R Kean, S Williams… - Msystems, 2021 - Am Soc Microbiol
Despite the strikingly high worldwide prevalence of vulvovaginal candidiasis (VVC),
treatment options for recurrent VVC (RVVC) remain limited, with many women experiencing …

Understanding cancer survivors' reasons to medicate with cannabis: A qualitative study based on the theory of planned behavior

H McTaggart‐Cowan, C Bentley, A Raymakers… - Cancer …, 2021 - Wiley Online Library
Background Prior to nonmedical cannabis legalization in Canada, individuals were only
able to access cannabis legally through licensed producers with medical authorization. Now …

How injectable opioid agonist treatment (iOAT) care could be improved? service providers and stakeholders' perspectives

T Magel, E Matzinger, S Blawatt… - … Prevention and Policy, 2024 - Taylor & Francis
Background Addressing inadequacies in the implementation of existing evidence-based
approaches into practice, such as injectable opioid agonist treatment (iOAT), is imperative …